Today: 21 May 2026
GE Aerospace stock price jumps on dividend hike as Wall Street rally sets up week-ahead test
7 February 2026
2 mins read

GE Aerospace stock price jumps on dividend hike as Wall Street rally sets up week-ahead test

New York, Feb 6, 2026, 20:45 EST — The market is shut for the day.

  • GE Aerospace rallied roughly 4.7% Friday, breaking a two-day losing streak.
  • Jet-engine maker bumped its quarterly dividend up to $0.47 per share.
  • Markets reopen Monday. Investors are eyeing delayed U.S. jobs numbers and inflation readings due out later in the week.

GE Aerospace (NYSE: GE) finished Friday up roughly 4.7%, closing at $321. The jet-engine manufacturer also bumped its quarterly dividend to 47 cents per share.

The dividend news comes as the stock hovers close to its highs from early January, capping off a solid rally over the last few months. U.S. markets are shut for the weekend; traders will be watching for any momentum when trading resumes Monday.

The real issue for investors: can aerospace suppliers actually meet demand? With aircraft and engine supplies still tight, airlines are hanging onto older jets longer. That bumps up demand for maintenance work, but also strains parts supplies, labor availability, and turnaround schedules.

GE’s board bumped up its quarterly dividend to $0.47 per share, marking a roughly 31% hike from the previous $0.36 payout. The dividend goes out April 27 to shareholders on record as of March 9—the same date as the ex-dividend, when shares trade without eligibility for that payment.

GE’s announcement landed during a rally that sent the Dow past 50,000 for the first time ever. The S&P 500 rose 1.97%, while the Nasdaq climbed 2.18%. “There’s real demand for AI products,” said Ross Mayfield, investment strategy analyst at Baird, referencing the outlook for increased AI infrastructure spending. Reuters

GE Aerospace edged past several industrial and defense names. Honeywell picked up 1.94% and RTX advanced 1.37% Friday, but GE’s volume jumped—roughly 5.7 million shares changed hands, topping its 50-day average, according to MarketWatch data. Shares closed about 4% shy of their Jan. 6, 52-week high.

GE has been riding the strength of its aftermarket segment — focusing on engine parts and repair as airlines keep older jets flying and deliveries stay sluggish. Back in late January, the company projected 2026 adjusted earnings per share in a range of $7.10 to $7.40, and called for revenue to climb at a low double-digit pace. CEO Larry Culp described the push into 2026 as carrying “solid momentum.” Reuters

The same supply crunch that lifts the services side can turn around and sting. Supply delays are just “the new norm” now, according to Jeffrey Lam, chief operating officer and president of commercial aerospace at ST Engineering. For airlines, that means more money out the door — IATA director general Willie Walsh called the added costs “very frustrating.” Reuters noted that global air passenger traffic in 2025 sat about 9.3% higher than 2019, with another 4.9% climb on deck this year. CFM International, the GE–Safran joint venture, responded by bumping output 25% in 2025, CEO Gael Meheust said, aiming for yearly growth of at least 10%. Reuters

With the brief government shutdown now in the rearview, attention turns to a packed macro calendar next week. The Labor Department’s January employment numbers land Feb. 11, while January CPI data follows on Feb. 13.

GE’s next key date is March 9, the day shares go ex-dividend. Eyes are also on the Singapore Airshow for any fresh headlines on orders or supply-chain updates, plus hints about whether production increases are going smoothly or running into fresh trouble.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Super Micro (SMCI) stock jumps, but SEC filing flags margin squeeze and customer concentration
Previous Story

Super Micro (SMCI) stock jumps, but SEC filing flags margin squeeze and customer concentration

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week
Next Story

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Go toTop